< Back to search
Filter
1

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma

for
Primary CNS Lymphoma
Location: San Francisco CA
Sponsor: James Rubenstein

Sex: All

Age: 18+

Code: NCT04656431

Phase1, Recruiting

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

for
Central Nervous System Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05625594

Phase1, Recruiting

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

for
Advanced Hodgkin Lymphoma, Classic Hodgkin Lymphoma,
Location: Boston MA, New York NY, St Louis MO, Seattle WA,
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06745076

Phase2, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Location: Boston MA, New Brunswick NJ, Chicago IL, Austin TX
Sponsor: Cellectis S.A.

Sex: All

Age: 18 - 70+

Code: NCT05607420

Phase1, Phase2, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Location: Philadelphia PA
Sponsor: Stephan Grupp MD PhD

Sex: All

Age: 0 - 29

Code: NCT06934382

Phase1, Recruiting

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

for
Acute Leukemia, Severe Aplastic Anemia, Non-hodgkin Lymphoma,
Location: Valhalla NY
Sponsor: Mitchell Cairo

Sex: All

Age: 0 - 30

Code: NCT04099966

Phase2, Recruiting

Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

for
Multiple Myeloma, Lymphoma, Acute Myelogenous Leukemia,
Location: Denver CO
Sponsor: Colorado Blood Cancer Institute

Sex: All

Age: 50 - 70

Code: NCT00304720

Phase2, Recruiting

Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: Denver CO
Sponsor: Colorado Blood Cancer Institute

Sex: All

Age: 18 - 49

Code: NCT00328237

Phase2, Recruiting

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

for
Peripheral T-cell Lymphoma
Location: Hackensack NJ, Greenville SC, Atlanta GA, Louisville KY,
Sponsor: CerRx, Inc.

Sex: All

Age: 18+

Code: NCT02495415

Phase2, Recruiting

A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

for
Mantle Cell Lymphoma (MCL)
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06788652

Recruiting

Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)

for
Malignant Lymphoma of Extranodal and/or Solid Organ Site,
Location: San Antonio TX
Sponsor: Cao Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT02575638

Phase1, Recruiting

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma,
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 0+

Code: NCT01513603

Phase2, Recruiting

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

for
Solid Tumor, Adult Lymphoma
Location: Pittsburgh PA, Houston TX, Duarte CA
Sponsor: Cyclacel Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05358379

Phase1, Phase2, Recruiting

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

for
Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma
Location: Hackensack NJ, Houston TX, Duarte CA
Sponsor: SIRPant Immunotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05967416

Phase1, Recruiting

Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma

for
Hodgkin's Lymphoma
Location: Houston TX
Sponsor: Tanox

Sex: All

Age: 18+

Code: NCT00441818

Phase1, Phase2, Recruiting

Lorlatinib Combinations in Lung Cancer

for
Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04292119

Phase1, Phase2, Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Relapsed Diffuse Large B-cell Lymphoma,
Location: West Reading PA, Greenville NC, Pittsburgh PA,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)

Sex: All

Age: 18+

Code: NCT04920617

Phase2, Recruiting

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

for
Diffuse Large B Cell Lymphoma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03736616

Phase2, Recruiting

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

for
Follicular Lymphoma,
Location: Louisville KY
Sponsor: Qilu Puget Sound Biotherapeutics (dba Sound Biologics)

Sex: All

Age: 18+

Code: NCT05003141

Phase1, Recruiting